Elizabeth E Reed insider trades

Open-market stock purchases and sales by Elizabeth E Reed, Chief Legal Officer and GC at Travere Therapeutics, Inc, from SEC Form 4 filings since Dec 13, 2010.

Recent trades

DateStockTradeValue
Sep 15, 2026TVTX Travere Therapeutics, IncSold$1.4M
Sep 15, 2026TVTX Travere Therapeutics, IncSold$869K
Sep 15, 2026TVTX Travere Therapeutics, IncSold$89.2K
Sep 15, 2026TVTX Travere Therapeutics, IncSold$19.6K
Sep 15, 2026TVTX Travere Therapeutics, IncBought (not open market)—
May 6, 2026TVTX Travere Therapeutics, IncSold$91.2K
May 5, 2026TVTX Travere Therapeutics, IncSold$101K
May 4, 2026TVTX Travere Therapeutics, IncSold$900K
May 4, 2026TVTX Travere Therapeutics, IncBought (not open market)—
May 4, 2026TVTX Travere Therapeutics, IncBought (not open market)—
May 4, 2026TVTX Travere Therapeutics, IncBought (not open market)—
Apr 15, 2026TVTX Travere Therapeutics, IncSold$218K
Apr 15, 2026TVTX Travere Therapeutics, IncSold$66.3K
Apr 14, 2026TVTX Travere Therapeutics, IncBought (not open market)—
Apr 14, 2026TVTX Travere Therapeutics, IncBought (not open market)—
Apr 14, 2026TVTX Travere Therapeutics, IncSold$1.5M
Apr 14, 2026TVTX Travere Therapeutics, IncSold$303K
Apr 14, 2026TVTX Travere Therapeutics, IncBought (not open market)—
Apr 13, 2026TVTX Travere Therapeutics, IncBought (not open market)—
Apr 1, 2026TVTX Travere Therapeutics, IncSold$300K
Apr 1, 2026TVTX Travere Therapeutics, IncBought (not open market)—
Mar 16, 2026TVTX Travere Therapeutics, IncSold$281K
Mar 16, 2026TVTX Travere Therapeutics, IncBought (not open market)—
Feb 17, 2026TVTX Travere Therapeutics, IncSold$156K
Feb 17, 2026TVTX Travere Therapeutics, IncSold$122K

Companies traded

  • TVTX Travere Therapeutics, Inc: 48 sales, last Sep 15, 2026
  • RTRX Travere Therapeutics, Inc: 17 sales, last Nov 16, 2020
  • CLDN Celladon Corp: other filings, last Jan 1, 2015
  • ANDS Anadys Pharmaceuticals Inc: other filings, last Jan 20, 2011

Get free alerts when Elizabeth E Reed files a new trade →